Suppr超能文献

脊髓灰质炎病毒中和表位:用中和性单克隆抗体进行分析和定位

Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.

作者信息

Emini E A, Jameson B A, Lewis A J, Larsen G R, Wimmer E

出版信息

J Virol. 1982 Sep;43(3):997-1005. doi: 10.1128/JVI.43.3.997-1005.1982.

Abstract

Two hybridomas (H3 and D3) secreting monoclonal neutralizing antibody to intact poliovirus type 1 (Mahoney strain) were established. Each antibody bound to a site qualitatively different from that to which the other antibody bound. The H3 site was located on intact virions and, to a lesser extent, on 80S naturally occurring empty capsids and 14S precursor subunits. The D3 site was found only on virions and empty capsids. Neither site was expressed on 80S heat-treated virions. The antibodies did not react with free denatured or undenatured viral structural proteins. Viral variants which were no longer capable of being neutralized by either one or the other antibody were obtained. Such variants arose during normal cell culture passage of wild-type virus and were present in the progeny viral population on the order of 10(-4) variant per wild-type virus PFU. Toluene-2,4-diisocyanate, a heterobifunctional covalent cross-linking reagent, was used to irreversibly bind the F(ab) fragments of the two antibodies to their respective binding sites. In this way, VP1 was identified as the structural protein containing both sites.

摘要

建立了两种分泌针对完整1型脊髓灰质炎病毒(马奥尼株)的单克隆中和抗体的杂交瘤(H3和D3)。每种抗体结合的位点在性质上与另一种抗体结合的位点不同。H3位点位于完整病毒粒子上,在较小程度上也位于80S天然存在的空衣壳和14S前体亚基上。D3位点仅在病毒粒子和空衣壳上发现。两个位点在80S热处理病毒粒子上均未表达。这些抗体不与游离的变性或未变性病毒结构蛋白反应。获得了不再能被其中任何一种抗体中和的病毒变体。这种变体在野生型病毒的正常细胞培养传代过程中出现,并且在子代病毒群体中的存在比例约为每野生型病毒PFU有10(-4)个变体。使用甲苯-2,4-二异氰酸酯,一种异双功能共价交联试剂,将两种抗体的F(ab)片段不可逆地结合到它们各自的结合位点。通过这种方式确定VP1为包含这两个位点的结构蛋白。

相似文献

1
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
J Virol. 1982 Sep;43(3):997-1005. doi: 10.1128/JVI.43.3.997-1005.1982.
7
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
J Gen Virol. 1985 May;66 ( Pt 5):1159-65. doi: 10.1099/0022-1317-66-5-1159.
8
Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
J Gen Virol. 1983 Dec;64 ( Pt 12):2803-8. doi: 10.1099/0022-1317-64-12-2803.
10
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
J Virol. 1997 Sep;71(9):6905-12. doi: 10.1128/JVI.71.9.6905-6912.1997.

引用本文的文献

1
Characterization of Poliovirus Neutralization Escape Mutants of Single-Domain Antibody Fragments (VHHs).
Antimicrob Agents Chemother. 2015 Aug;59(8):4695-706. doi: 10.1128/AAC.00878-15. Epub 2015 May 26.
2
The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Hum Vaccin Immunother. 2015;11(11):2723-33. doi: 10.1080/21645515.2015.1011975. Epub 2015 Feb 25.
3
Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20242-7. doi: 10.1073/pnas.1320041110. Epub 2013 Nov 25.
5
Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.
Eur J Nutr. 2005 Oct;44(7):406-13. doi: 10.1007/s00394-004-0541-8. Epub 2004 Dec 1.
7
Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
Clin Diagn Lab Immunol. 1997 Nov;4(6):659-64. doi: 10.1128/cdli.4.6.659-664.1997.
8
Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9775-9. doi: 10.1073/pnas.91.21.9775.
9
Monoclonal antibodies to Rhizobium meliloti and surface mutants insensitive to them.
J Bacteriol. 1984 Oct;160(1):454-7. doi: 10.1128/jb.160.1.454-457.1984.
10
The application of monoclonal antibodies in the study of viruses.
Adv Virus Res. 1984;29:95-130. doi: 10.1016/s0065-3527(08)60406-6.

本文引用的文献

1
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.
Biochem J. 1959 Sep;73(1):119-26. doi: 10.1042/bj0730119.
2
The D to C change in poliovirus particles.
Br J Exp Pathol. 1959 Dec;40(6):605-20.
3
Principles of immunization as applied to poliomyelitis and influenza.
Am J Public Health Nations Health. 1953 Nov;43(11):1384-98. doi: 10.2105/ajph.43.11.1384.
4
Picornaviral structure and assembly.
Microbiol Rev. 1981 Jun;45(2):287-315. doi: 10.1128/mr.45.2.287-315.1981.
5
Identification of the initiation site of poliovirus polyprotein synthesis.
J Virol. 1982 Jun;42(3):1017-28. doi: 10.1128/JVI.42.3.1017-1028.1982.
7
Cleavage sites within the poliovirus capsid protein precursors.
J Virol. 1982 Jan;41(1):340-4. doi: 10.1128/JVI.41.1.340-344.1982.
8
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans.
J Gen Virol. 1981 Oct;56(Pt 2):337-47. doi: 10.1099/0022-1317-56-2-337.
9
The fate of VPg during in vitro translation of poliovirus RNA.
FEBS Lett. 1981 Sep 28;132(2):219-23. doi: 10.1016/0014-5793(81)81164-7.
10
A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
Virology. 1981 Nov;115(1):211-5. doi: 10.1016/0042-6822(81)90103-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验